A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).

MLA

Cosmi, B., et al. “A Randomized Double-Blind Study of Low-Molecular-Weight Heparin (Parnaparin) for Superficial Vein Thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).” Journal of Thrombosis and Haemostasis : JTH, vol. 10, no. 6, June 2012, pp. 1026–35. EBSCOhost, https://doi.org/10.1111/j.1538-7836.2012.04727.x.

APA

Cosmi, B., Filippini, M., Tonti, D., Avruscio, G., Ghirarduzzi, A., Bucherini, E., Camporese, G., Imberti, D., & Palareti, G. (2012). A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis : JTH, 10(6), 1026–1035. https://doi.org/10.1111/j.1538-7836.2012.04727.x

Chicago

Cosmi, B, M Filippini, D Tonti, G Avruscio, A Ghirarduzzi, E Bucherini, G Camporese, D Imberti, and G Palareti. 2012. “A Randomized Double-Blind Study of Low-Molecular-Weight Heparin (Parnaparin) for Superficial Vein Thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).” Journal of Thrombosis and Haemostasis : JTH 10 (6): 1026–35. doi:10.1111/j.1538-7836.2012.04727.x.